Paul Dowling

Kildare, L, Ireland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 108 publications

Publisher Correction: Collagen VI is a fibrosis-associated signal disrupting muscle regeneration across distinct human myopathies.

Publisher Correction: Collagen VI is a fibrosis-associated signal disrupting muscle regeneration across distinct human myopathies.

Journal: EMBO reports
Published: July 01, 2026

Potential proteomic biomarkers for monitoring clinical studies in Duchenne/Becker muscular dystrophy.

Potential proteomic biomarkers for monitoring clinical studies in Duchenne/Becker muscular dystrophy.

Journal: Expert review of proteomics
Published: May 04, 2026

Tissue Microarray Analysis Reveals Heterogeneous Expression of Talin-1 and Lactate Dehydrogenase A in Non-small Cell Lung Cancer: Implications for Biomarker Reliability.

Tissue Microarray Analysis Reveals Heterogeneous Expression of Talin-1 and Lactate Dehydrogenase A in Non-small Cell Lung Cancer: Implications for Biomarker Reliability.

Journal: Cureus
Published: March 16, 2026

TP53 mutation drives unique transcriptional and functional vulnerabilities independent of del(17p) in multiple myeloma.

TP53 mutation drives unique transcriptional and functional vulnerabilities independent of del(17p) in multiple myeloma.

Journal: iScience
Published: February 23, 2026

2D-DIGE proteomics.

2D-DIGE proteomics.

Journal: Advances in clinical chemistry
Published: February 18, 2026

Collagen VI is a fibrosis-associated signal disrupting muscle regeneration across distinct human myopathies.

Collagen VI is a fibrosis-associated signal disrupting muscle regeneration across distinct human myopathies.

Journal: EMBO reports
Published: December 18, 2025

Collagen VI is a fibrosis-associated signal disrupting muscle regeneration across distinct human myopathies.

Collagen VI is a fibrosis-associated signal disrupting muscle regeneration across distinct human myopathies.

Journal: EMBO reports
Published: December 18, 2025

Phosphoproteomic Profiling of Multiple Myeloma Based on Ex Vivo Drug Sensitivity Resistance Testing Identifies Phosphorylation Signatures Associated with Drug Response.

Phosphoproteomic Profiling of Multiple Myeloma Based on Ex Vivo Drug Sensitivity Resistance Testing Identifies Phosphorylation Signatures Associated with Drug Response.

Journal: Biomolecules
Published: December 08, 2025

Metabolic alterations in multiple myeloma and extramedullary disease- a novel niche of therapeutic targets.

Metabolic alterations in multiple myeloma and extramedullary disease- a novel niche of therapeutic targets.

Journal: Blood reviews
Published: October 06, 2025

Proteomic Profiling of Myofiber Repair Annexins and Their Role in Duchenne Muscular Dystrophy.

Proteomic Profiling of Myofiber Repair Annexins and Their Role in Duchenne Muscular Dystrophy.

Journal: Proteomics
Published: September 03, 2025

Gel electrophoresis-based proteoform separation and analysis.

Gel electrophoresis-based proteoform separation and analysis.

Journal: Advances in clinical chemistry
Published: July 11, 2025

Serum protein biomarker signature of Duchenne muscular dystrophy.

Serum protein biomarker signature of Duchenne muscular dystrophy.

Journal: European journal of translational myology
Published: May 06, 2025
Showing 1-12 of 108

Last Updated: 09/26/2026